The Amplify Weight Loss Drug & Treatment ETF (THNR) seeks investment results that generally correspond to the performance of the VettaFi Weight Loss Drug & Treatment Index. THNR provides access to global companies involved in the pharmaceutical manufacturing of GLP-1 agonist or enablers of such businesses.

Exploring Balance & Strength in Energy & Income Exposure

Audio Commentary by Tim Seymour, IDVO Portfolio Manager

International equities traded lower in March as the Iran war triggered both inflation and growth fears, and central banks (European Central Bank, Bank of Japan) tightened policy or threatened it. The spike in oil prices highlighted the dependence many international economies have on oil imports for consumption and industrial sectors. International equities traded lower in sympathy with risk reduction and rotation yet continued to show resilience rooted in cheaper valuations and higher dividends than U.S. markets. Volatility peaked in the third week of the month after Brent prices surged past $110/bbl (dollars per barrel), and equities rallied from their lows (approximately -13% at the intraday bottom from the start of the month) as ceasefire headlines hit the tape.

Chicago, April 29, 2026—Amplify ETFs announces April income distributions for its income ETFs.

CHICAGO, April 30, 2026 – Amplify ETFs, a leading provider of breakthrough ETF solutions, announces the filing of the Amplify S&P 500 Dividend Drivers ETF (DRVR).

Audio Commentary by Tim Seymour

Audio Commentary by Tim Seymour, IDVO Portfolio Manager

Firm recognized by InvestmentNews for annual industry awards May 7 , 2026 – Chicago – Amplify ETFs, a leading provider of breakthrough ETF solutions, announces it has been named an Excellence Awardee in the 2026 InvestmentNews Awards, earning recognition in the ETF Provider of the Year category.

The market rebound in April demonstrates that positive swings can occur even during challenging times.